Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum

DISCUSSION: These findings emphasize that treatments that remove Aβ and completely stop downstream effects on tau and neurodegeneration would only be partially effective in slowing of cognitive decline or reversing cognitive impairment.PMID:34647694 | DOI:10.1002/alz.12480
Source: The Journal of Alzheimers Association - Category: Psychiatry Authors: Source Type: research